[1
]
NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York,
New York; Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine,
New Haven, Connecticut; Clinical Trials Center, Cardiovascular Research Foundation,
New York, New York. Electronic address: bb2813@cumc.columbia.edu.
[2
]
NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York,
New York; Clinical Trials Center, Cardiovascular Research Foundation, New York, New
York. Electronic address: mvm2122@cumc.columbia.edu.
[3
]
Respiratory Department, Hospital Ramón y Cajal and Medicine Department, Universidad
de Alcalá (Instituto de Ramón y Cajal de Investigación Sanitaria), Centro de Investigación
Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain.
[4
]
NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York,
New York.
[5
]
Department of Medicine and Surgery, University of Insubria, Varese, Italy.
[6
]
McGovern Medical School, University of Texas Health Science Center at Houston, Houston,
Texas.
[7
]
Department of Cardiology, Chinese PLA General Hospital, Beijing, China.
[8
]
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University
of Science and Technology, Wuhan, China.
[9
]
Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia,
Pennsylvania; Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center,
Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia,
Pennsylvania; Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.
[10
]
University of Vermont Medical Center, Burlington, Vermont.
[11
]
Department of Vascular Medicine, University of Montpellier, Centre Hospitalier Universitaire
Montpellier, InnoVTE F-CRIN Network, Montpellier, France.
[12
]
Oncology Unit GPP, Sotiria General Hospital Athens School of Medicine, Athens, Greece.
[13
]
Harvard Medical School, Boston, Massachusetts; Beth Israel Deaconess Medical Center,
Boston, Massachusetts.
[14
]
Laboratory of Clinical Chemistry and Hematology, University Hospital of Verona, Verona,
Italy.
[15
]
Haematology Laboratory, Institute of Clinical Pathology and Medical Research, NSW
Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia; Sydney
Centres for Thrombosis and Haemostasis, Westmead, New South Wales, Australia.
[16
]
Loyola University Medical Center, Chicago, Illinois.
[17
]
Pritzker School of Medicine, University of Chicago, Chicago, Illinois.
[18
]
Pritzker School of Medicine, University of Chicago, Chicago, Illinois; Division of
Vascular Medicine, Department of Medicine, NorthShore University HealthSystem, Skokie,
Illinois.
[19
]
Clinical Trials Center, Cardiovascular Research Foundation, New York, New York.
[20
]
Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII,
University of Milan Bicocca, Bergamo, Italy.
[21
]
Auckland City Hospital, Auckland, New Zealand.
[22
]
St Thomas' Hospital, London, United Kingdom.
[23
]
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hofstra University,
Hempstead, New York.
[24
]
Center for Bioethics and Social Science in Medicine, University of Michigan, Ann Arbor,
Michigan; Frankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan.
[25
]
Population Health Research Institute, Hamilton Health Sciences, McMaster University,
Hamilton, Ontario, Canada.
[26
]
Harvard Medical School, Boston, Massachusetts; Massachusetts General Hospital, Boston,
Massachusetts.
[27
]
Department of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical
University, Moscow, Russia; McMaster University, Hamilton, Ontario, Canada; Thrombosis
and Atherosclerosis Research Institute, Hamilton, Ontario, Canada.
[28
]
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
[29
]
Harvard Medical School, Boston, Massachusetts; Brigham and Women's Hospital, Boston,
Massachusetts.
[30
]
Vanderbilt University School of Medicine, Nashville, Tennessee.
[31
]
INSERM U1148, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, FACT (French
Alliance for Cardiovascular Trials), Paris, France; Université Paris, Paris, France;
Royal Brompton Hospital, Imperial College London, London, United Kingdom.
[32
]
Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Zena
and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount
Sinai, New York, New York.
[33
]
Cologne Cardiovascular Research Center, Heart Center, Department of Cardiology, University
of Cologne, Cologne, Germany.
[34
]
NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York,
New York; Clinical Trials Center, Cardiovascular Research Foundation, New York, New
York.
[35
]
Department of Internal Medicine, Hospital Universitari Germans Trials i Pujol, Universidad
Católica San Antonio de Murcia, Barcelona, Spain.
[36
]
Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven,
Connecticut; Department of Health Policy and Administration, Yale School of Public
Health, New Haven, Connecticut; Section of Cardiovascular Medicine, Department of
Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
[37
]
Center for Thrombosis and Hemostasis, Johannes Gutenberg University of Mainz, Mainz,
Germany.
[38
]
McMaster University, Hamilton, Ontario, Canada; Thrombosis and Atherosclerosis Research
Institute, Hamilton, Ontario, Canada.
[39
]
Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, University
of Liverpool, Liverpool, United Kingdom; Aalborg University, Aalborg, Denmark.
